Source: GlobeNewswire

Press Release: Mesoblast : First Three Children to Commence Treatment With Ryoncil

United States Centers for Medicare and Medicaid Services (CMS) Mandates Ryoncil® CoverageUnited States Centers for Medicare and Medicaid Services (CMS) Mandates Ryoncil® Coverage

Read full article »
Mesoblast's Competitors | Mesoblast's News | Mesoblast's Financials
Stay up-to-date with the latest news on Mesoblast
Annual Revenue
$5.0-25M
Employees
25-100
Silviu Itescu's photo - Managing Director & CEO of Mesoblast

Managing Director & CEO

Silviu Itescu

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Mesoblast